Evidence-based health economics: Answers in search of questions?

Evidence-Based Medicine: In Its Place

Volumn , Issue , 2004, Pages 50-61

  Birch, Stephen ^a   Gafni, Amiram ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84906447068     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780203493694     Document Type: Chapter

References (26)

1. Becker, G. (1965) Theory of the allocation of time, Economic Journal, 75: 493-517.
2. Birch, S. (1996) As a matter of fact: evidence-based decision-making unplugged, Health Economics, 6: 547-60.
3. Birch, S. (2002) Making the problem fit the solution: evidence-based decisionmaking and 'dolly' economics, in C. Donaldson, M. Mugford and L. Vale (eds) Evidence-Based Health Economics: From Effectiveness to Efficiency in Systematic Review, London: BMJ Books.
4. Birch, S. and Gafni, A. (1996) Cost effectiveness and cost utility analyses: methods for the non-economic evaluation of health care programs and how we can do better, in E. Geisler and O. Heller (eds) Managing Technology in Health Care, New York: Wiley.
5. Birch, S. and Gafni, A. (2002a) Economics and the evaluation of vaccination programmes:the importance of context, Vaccinations: Children and Practice, 5: 38-42.
6. Birch, S. and Gafni, A. (2002b) On being NICE in the UK: guidelines for technology appraisal for the NHS in England and Wales, Health Economics, 8: 185-91.
7. Birch, S. and Gafni, A. (2003) Economics and the evaluation of health care programmes:generalisability of methods and implications for generalisability of results, Health Policy, 64: 207-19.
8. Cochrane, A. (1972) Effectiveness and Efficiency: Random Reflections on Health Services, London: Nuffield Provincial Hospitals Trust.
9. Donaldson, C., Mugford, M. and Vale, L. (2002a) Evidence-Based Health Economics:From Effectiveness to Efficiency in Systematic Review, London: BMJ Books.
10. Donaldson, C., Mugford, M. and Vale, L. (2002b) Using systematic reviews in economic evaluations: the basic principles, in C. Donaldson, M. Mugford and L. Vale (eds) Evidence-Based Health Economics: From Effectiveness to Efficiency in Systematic Review, London: BMJ Books.
11. Drummond, M., O'Brien, B., Stoddart, G. and Torrance, G. (1996) Methods for the Economic Evaluation of Health Care Programmes, 2nd edn, New York: Oxford University Press.
12. Ehrlich, I. (2000) Uncertain lifetime, life protection and the value of life saving, Journal of Health Economics, 19: 341-67.
13. Gafni, A. and Birch, S. (1993) Guidelines for the adoption of a new technology: a potential prescription for uncontrolled growth in expenditures and how to avoid it, Canadian Medical Association Journal, 148: 913-17.
14. Gafni, A. and Birch, S. (2003a) Inclusion of drugs in provincial drug benefit programs:should 'reasonable decisions' lead to uncontrolled growth in expenditures?, Canadian Medical Association Journal, 168: 849-51.
15. Gafni, A. and Birch, S. (2003b) NICE methodological guidelines and decisionmaking in the United Kingdom National Health Service, PharmacoEconomics, 21: 149-57.
16. Grossman, M. (1972) On the concept of health capital and the demand for health, Journal of Political Economy, 80: 223-55.
17. House of Commons Select Committee (2002) Health: National Institute for Clinical Excellence, London: The Stationery Office.
18. Hutchison, B., Birch, S., Hurley, J., Lomas, J. and Stratford-Devai, F. (1996) Effect of a financial incentive to reduce hospital utilization in capitated primary care practice, Canadian Medical Association Journal, 154: 653-61.
19. Laupacis, A. (2002) Inclusion of drugs in provincial drug benefit programs: who is making these decisions, and are they the right ones?, Canadian Medical Association Journal, 166: 44-7.
20. Laupacis, A., Feeny, D., Detsky, A. and Tugwell, P. (1992) How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluation, Canadian Medical Association Journal, 146: 473-81.
21. National Institute for Clinical Excellence (2001) Technical Guidance for Manufacturers and Sponsors on Making a Submission to a Technology Appraisal, London: NICE.
22. Sackett, D. and Rosenberg, W. (1995) On the need for evidence-based medicine, Health Economics, 4: 249-54.
23. Sackett, D., Haynes, B. and Tugwell, P. (1985) Clinical Epidemiology: A Basic Science for Clinical Medicine, Toronto: Little, Brown.
24. Taylor, R. (2002) Generating national guidance: a NICE model? Paper presented at the Fifth International Conference on Strategic Issues in Health Care Management Policy, Finance and Performance in Health Care, St Andrews, Scotland, UK, 11-13 April.
25. Taylor, R., Hutton, J. and Culyer, A. (2003) Developing the revised NICE appraisal technical guidance to manufacturers and sponsors: opportunity or threat?, PharmacoEconomics, 20: 1031-8.
26. Williams, A. (1983) The economic role of health indicators, in G. Teeling-Smith (ed.) Measuring the Social Benefits of Medicine, London: Office of Health Economics.